Target
TGF-beta receptor type-1
Ligand
BDBM481195
Substrate
n/a
Meas. Tech.
Kinase Activity Assay
IC50
39.0±n/a nM
Citation
 Yu, SYang, FYan, JWu, XHe, FTao, W Five-membered heteroaryl ring bridged ring derivative, preparation method therefor and medical use thereof US Patent  US10906905 Publication Date 2/2/2021 
Target
Name:
TGF-beta receptor type-1
Synonyms:
ALK-5 | ALK5 | Activin A receptor type II-like protein kinase of 53kD | Activin receptor-like kinase 5 | SKR4 | Serine/threonine-protein kinase receptor R4 | TGF-beta receptor type I | TGF-beta type I receptor | TGFBR1 | TGFR-1 | TGFR1_HUMAN | TbetaR-I | Transforming growth factor-beta receptor type I
Type:
enzyme
Mol. Mass.:
55968.24
Organism:
Homo sapiens (Human)
Description:
P36897
Residue:
503
Sequence:
MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM
  
Inhibitor
Name:
BDBM481195
Synonyms:
US10906905, Example 35-1
Type:
Small organic molecule
Emp. Form.:
C24H21N5O
Mol. Mass.:
395.4564
SMILES:
Cc1cccc(n1)-c1nn2[C@@H]3CC[C@@H](C3)c2c1-c1ccnc2ccc(cc12)C(N)=O |r,wD:13.14,10.15,(-3.04,-6.32,;-3.04,-4.78,;-4.37,-4.01,;-4.37,-2.47,;-3.04,-1.7,;-1.71,-2.47,;-1.71,-4.01,;-.37,-1.7,;1.39,-2.98,;2.06,-1.18,;3.6,-1.18,;4.37,.15,;3.6,1.48,;2.06,1.48,;3.15,.39,;1.29,.15,;-.21,-.17,;-1.36,.86,;-2.82,.38,;-3.97,1.41,;-3.65,2.92,;-2.18,3.4,;-1.86,4.9,;-.4,5.38,;.75,4.35,;.43,2.84,;-1.04,2.37,;2.21,4.82,;2.57,6.32,;3.3,3.74,)|
Structure:
Search PDB for entries with ligand similarity: